Huvepharma Inc. Introduces New Vaccine to Combat Necrotic Enteritis
Huvepharma Inc. introduces AVERT™ NE, an innovative new vaccine to help control necrotic enteritis (NE) due to Clostridium perfringens Type A. Avert™ NE utilizes proprietary and unique recombinant attenuated Salmonella vaccine (RASV) technology from Curtiss Healthcare, Inc. as the delivery platform to elicit an immune response to protect chickens from necrotic enteritis (NE).